Kinetic study of CYP3A4 activity on verapamil by capillary electrophoresis.

Jie Zhang,Pham Thi Thanh Ha,Yijia Lou,Jos Hoogmartens,Ann Van Schepdael
DOI: https://doi.org/10.1016/j.jpba.2005.04.019
IF: 3.571
2005-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:The use of capillary electrophoresis (CE) for the determination of CYP3A4 activity with verapamil as a substrate was investigated. CYP3A4 activity was determined by the quantitation of the product, norverapamil, based on separation by CE. The separation conditions were as follows: capillary, 80.5cm (75μm i.d., 72cm effective length); 50mM sodium phosphate buffer (pH 8.8); 20kV (100μA) applied voltage; UV detection at 200nm; capillary temperature, 25 °C. With the developed CYP3A4 activity assay and the Lineweaver–Burk equation, the Michaelis–Menten parameters Km and Vmax for formation of norverapamil from verapamil in the presence of CYP3A4 were determined and were 22.8±2.5μM and 7.67±0.26pmol/min/pmol (or 983pmol/min/mg) CYP3A4, respectively.
What problem does this paper attempt to address?